Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
14.27+0.14 (+0.99%)
At close: 04:00PM EST
14.27 0.00 (0.00%)
After hours: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/6/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 316.28
52 Week Low 32.36
50-Day Moving Average 312.89
200-Day Moving Average 38.06

Share Statistics

Avg Vol (3 month) 3161.59k
Avg Vol (10 day) 3128.6k
Shares Outstanding 527.5M
Implied Shares Outstanding 6N/A
Float 87.27M
% Held by Insiders 18.35%
% Held by Institutions 150.46%
Shares Short (Oct 13, 2022) 4106.51k
Short Ratio (Oct 13, 2022) 40.62
Short % of Float (Oct 13, 2022) 40.71%
Short % of Shares Outstanding (Oct 13, 2022) 40.70%
Shares Short (prior month Sep 14, 2022) 493.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 30, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-22.25%
Return on Equity (ttm)-37.18%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-43.94M
Diluted EPS (ttm)-33.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)102.48M
Total Cash Per Share (mrq)7.87
Total Debt (mrq)1.22M
Total Debt/Equity (mrq)1.23
Current Ratio (mrq)19.87
Book Value Per Share (mrq)2.62

Cash Flow Statement

Operating Cash Flow (ttm)-36.66M
Levered Free Cash Flow (ttm)-22.58M
Advertisement
Advertisement